«Balb 3t3 Cells

Below is an extended Balb 3t3 Cells patents listing. Click here to return to the Balb 3t3 Cells main in depth entry.

Patents :
US Patent No.	Title
6482929	Antibodies to ARF-p19
6699972	Chimeric protein and method of controlling tumor growth using the protein
6716575	Diagnosis and treatment of AUR1 and/or AUR2 related disorders
6720158	Splice variants of BRCA1
6740521	High-sensitive detection of environmental pollutants
6767700	Tumor cells having tumorigenic potential but lacking invasive/metastatic potential, method for preparing them and screening method for metastasis-related genes using the same
6841579	Diagnosis and treatment of AUR1 and/or AUR2 related disorders
6844177	Diagnosis and treatment of PTP04 related disorders
6844183	Antibiotics RK-1061 and process for preparing the same
6846672	Mitogenic oxygenase regulators
6903074	Neuromedin b and somatostatin receptor agonists
6693105	Hydroxyl-containing compounds
6682917	Protein having a ribonucleotide Reductase activity and a DNA thereof
6664098	Differentiation inhibitory agent
6498147	Suppression of nuclear factor-.kappa.b dependent processes using oligonucleotides
6555328	Screening methods for altering circadian rhythms and for human casein kinase I .delta. and/or .epsilon. phosphorylation of human clock proteins, period 1, -2 and -3
6558650	Enhancement of cellular gallium uptake
6565856	Compounds and methods for treatment and diagnosis of chlamydial infection
6586203	ARF-P19, a novel regulator of the mammalian cell cycle
6593353	p53 inhibitors and therapeutic use of the same
6608105	TNF-.alpha. production inhibitor comprising kavalactone as an active ingredient
6608186	Pyranosyl nucleic acid conjugates
6620603	Human mitogenic oxidase
6653326	Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
6916654	Universal donor cells
6982277	P53 inhibitors and therapeutic use of the same
7199152	TNF-.alpha. production inhibitor comprising kavalactone as an active ingredient
7202052	Mitogenic oxygenase regulators
7202053	Mitogenic oxygenase regulators
7211644	Diagnostic markers of human female infertility
7226769	Dual oxidases as mitogenic and endocrine regulators
7244590	Regulatory protein for Nox enzymes
7247709	Mitogenic oxygenases
7256279	Protein having ribonucleotide reductase activity and DNA thereof
7268121	Suppression of nuclear factor-.kappa.B dependent processes using oligonucleotides
7323450	Complex immuno-gene medical composition for inhibiting tumor cells
7192590	Compounds for treatment of infectious and immune system disorders and methods for their use
7160722	Master bone formation transcription factor: compositions and methods of use
7148239	Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
7008956	p53 inhibitors and therapeutic use of the same
7012087	p53 inhibitors and therapeutic use of the same
7029673	Regulatory protein for Nox enzymes
7041295	Compounds for treatment of infectious and immune system disorders and methods for their use
7041503	Modified myelin basic protein molecules
7045351	Mitogenic oxygenases
7048923	Antibodies to mitogenic oxygenases
7091316	Protein induced by homogeneous blood transfusion and DNA encoding the same
7115710	Diagnosis and treatment of PTP related disorders
7119174	Diagnosis and treatment of AUR1 and/or AUR2 related disorders
7361340	Antibody against tumor specific antigen as target

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.